Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands

(NASDAQ:ONCY) Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Sept. 2, 2025 /PRNewswire/ -- Cancer innovation is reaching new heights as the FDA approved b...

What are the reimbursement, manufacturing scalability, and regulatory rollout timelines that could influence ONCY's earnings outlook? What is the potential market size and revenue upside from the approved aggressive malignancy indications compared to ONCY's existing pipeline and peers? How will the FDA approval of Modeyso affect ONCY's short‑term stock volatility and price target?
Symbol: ONCY
Regulatory
13 days ago
Read more prnewswire

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

(NASDAQ:PMCB) LAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), today announced that it has increased its stake in TNF Pharmaceuticals (Nasdaq: TNF...

What regulatory, adoption and competitive risks are associated with the new accelerator technology, and how might they influence the stocks' price trajectories? What impact could the Light Speed Computing platform’s exposure to cryptocurrency applications have on the valuation and risk profile of both PMCB and TNFA relative to peers? How will PharmaCyte's increased $3 million stake in TNF and the LightSolver licensing deal affect its near‑term earnings and cash flow?
Symbol: PMCB
Investments
13 days ago
Read more businesswire